Duke/UNC CTSA Consortium Grants

This T1/T2 pilot program is designed to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.

Cross-disciplinary basic research addressing the development of therapies, diagnostics or devices applicable to human disease and clinical research/trials are areas of interest for these awards. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels.

Proposed projects must involve a lead investigator from Duke and a lead investigator from UNC-Chapel Hill. Proposals are encouraged from new teams of investigators from different disciplines. Applicants at each institution must have a full-time faculty appointment.

The research activities at each participating institution will be funded by that institution's CTSA. Duke CTSI and NC TraCS will each fund up to $25,000 direct costs, for a total of $50,000 per collaborative project.

The budget period is for 12 months beginning between January 1 and May 1, 2017 and ending no later than April 30, 2018. Proposals are submitted via the Duke CTSA online system – please see the RFA below for more information.

View the Duke/UNC CTSA Consortium RFA (pdf)

Submission Due Date

October 5, 2017